ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 77 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $6,409,000 | -5.4% | 650,000 | +4.0% | 0.45% | -19.2% |
Q4 2020 | $6,775,000 | +5.2% | 625,000 | 0.0% | 0.55% | -3.3% |
Q3 2020 | $6,438,000 | -38.3% | 625,000 | +25.0% | 0.57% | -49.3% |
Q2 2020 | $10,440,000 | +94.3% | 500,000 | -9.1% | 1.13% | +49.8% |
Q1 2020 | $5,374,000 | -28.2% | 550,000 | -15.4% | 0.75% | -8.3% |
Q4 2019 | $7,488,000 | +1048.5% | 650,000 | +443.1% | 0.82% | +901.2% |
Q3 2019 | $652,000 | -54.2% | 119,673 | 0.0% | 0.08% | -47.8% |
Q2 2019 | $1,423,000 | +127.0% | 119,673 | 0.0% | 0.16% | +115.1% |
Q1 2019 | $627,000 | +66.3% | 119,673 | 0.0% | 0.07% | +69.8% |
Q4 2018 | $377,000 | -59.5% | 119,673 | -22.3% | 0.04% | -53.8% |
Q3 2018 | $931,000 | +14.1% | 153,965 | 0.0% | 0.09% | +10.7% |
Q2 2018 | $816,000 | +10.7% | 153,965 | +21.2% | 0.08% | -7.7% |
Q1 2018 | $737,000 | +65.6% | 127,006 | 0.0% | 0.09% | +51.7% |
Q4 2017 | $445,000 | -20.8% | 127,006 | -17.5% | 0.06% | -16.7% |
Q3 2017 | $562,000 | +46.0% | 154,006 | 0.0% | 0.07% | +30.9% |
Q2 2017 | $385,000 | -7.5% | 154,006 | 0.0% | 0.06% | -16.7% |
Q1 2017 | $416,000 | -6.9% | 154,006 | 0.0% | 0.07% | -23.3% |
Q4 2016 | $447,000 | -99.9% | 154,006 | 0.0% | 0.09% | -14.9% |
Q3 2016 | $632,965,000 | +129872.3% | 154,006 | 0.0% | 0.10% | +17.4% |
Q2 2016 | $487,000 | – | 154,006 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 919,000 | $4,816,000 | 2.29% |
RTW INVESTMENTS, LP | 6,256,840 | $32,786,000 | 2.24% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $2,515,000 | 1.08% |
Bpifrance SA | 828,262 | $4,340,000 | 0.49% |
WS MANAGEMENT LLLP | 888,722 | $4,657,000 | 0.28% |
Eventide Asset Management | 1,146,580 | $6,008,000 | 0.21% |
683 Capital Management, LLC | 362,386 | $1,899,000 | 0.17% |
Orbimed Advisors | 1,243,200 | $6,514,000 | 0.10% |
Sofinnova Investments, Inc. | 159,237 | $835,000 | 0.08% |
Rhenman & Partners Asset Management AB | 119,673 | $627,000 | 0.07% |